HomeWXXWY • OTCMKTS
add
Wuxi Biologics Cayman ADR
Nakaraang pagsara
$2.77
Sakop ng araw
$2.72 - $2.76
Sakop ng taon
$2.69 - $13.25
Market cap
48.43B HKD
Average na Volume
85.57K
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (CNY) | Dis 2023info | Y/Y na pagbabago |
|---|---|---|
Kita | 4.27B | 5.95% |
Gastos sa pagpapatakbo | 818.44M | 13.31% |
Net na kita | 566.53M | -39.90% |
Net profit margin | 13.26 | -43.28% |
Kita sa bawat share | — | — |
EBITDA | 1.06B | -1.78% |
Aktuwal na % ng binabayarang buwis | 25.05% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CNY) | Dis 2023info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 11.24B | 29.02% |
Kabuuang asset | 56.58B | 14.15% |
Kabuuang sagutin | 12.56B | -5.94% |
Kabuuang equity | 44.02B | — |
Natitirang share | 4.22B | — |
Presyo para makapag-book | 0.29 | — |
Return on assets | 3.60% | — |
Return on capital | 4.19% | — |
Cash Flow
Net change in cash
| (CNY) | Dis 2023info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 566.53M | -39.90% |
Cash mula sa mga operasyon | — | — |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | — | — |
Net change in cash | — | — |
Malayang cash flow | — | — |
Tungkol
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, and began building out capabilities and facilities required for biologics discovery, development and GMP manufacturing. WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Itinatag
2010
Website
Mga Empleyado
12,740
